Cluster headache treatment market size was valued at $376.0 million in 2025 and is projected to reach $715.3 million by 2035, growing at a CAGR of 6.20% between 2026 and 2035. Cluster headache treatment includes pharmacological therapies such as triptans, CGRP inhibitors, corticosteroids, and calcium channel blockers, along with device-based solutions including neuromodulation technologies and oxygen delivery systems. These treatments are essential for managing one of the most severe primary headache disorders, enabling rapid pain relief and long-term prevention. With increasing awareness of neurological conditions, improved diagnosis rates, and advancements in targeted therapies, the adoption of cluster headache treatment solutions is steadily increasing across global healthcare systems.

Brand protection market was valued at $2.4 billion in 2025 and is projected to reach $4.5 billion by 2035, growing at a CAGR of 6.7% during 2026–2035. This growth is primarily driven by the rapid rise in counterfeiting, product piracy, and digital fraud across multiple industries. According to the Organisation for Economic Co-operation and Development, counterfeit goods account for nearly $464 billion in global trade annually, posing serious threats to brand integrity, revenue streams, and consumer safety. As a result, companies are increasingly investing in advanced brand protection technologies to safeguard products and maintain customer trust. The adoption of technologies such as RFID, serialization, holograms, and AI-based monitoring systems is significantly enhancing product authentication and supply chain visibility. These solutions enable real-time tracking, traceability, and verification, particularly in high-risk sectors such as pharmaceuticals, luxury goods, and consumer electronics. Regulatory pressures and rising consumer awareness regarding product authenticity are further accelerating the demand for robust brand protection strategies.

Bioplastics market size was valued at $3.3 billion in 2025 and is projected to reach $10.8 billion  by 2035, expanding at a CAGR of 12.7% during 2026–2035. The market is witnessing steady expansion driven by increasing regulatory pressure to reduce plastic waste and a global shift toward sustainable materials across key industries such as packaging, agriculture, and consumer goods. A major macroeconomic driver for the market is the rising environmental impact of conventional plastics and the need for renewable alternatives. According to the International Energy Agency, the petrochemical sector, including plastics, is expected to account for nearly one-third of global oil demand growth by 2030, highlighting the urgency to adopt bio-based substitutes. Additionally, global plastic production exceeds 400 million tons annually, intensifying environmental concerns and regulatory actions. The European Commission has introduced stringent directives to curb single-use plastics, which is significantly accelerating the adoption of biodegradable and bio-based materials.

Automated container terminal market was valued at $8.8 billion in 2025 and is projected to reach $16.6 billion by 2035, expanding at a CAGR of 6.7% during 2026–2035. Automated container terminals utilize advanced equipment such as Automated Ship-to-Shore (STS) cranes, Automated Yard Cranes, Automated Guided Vehicles (AGVs), and AI-powered Terminal Operating Systems (TOS) to streamline port operations. These technologies enhance cargo handling efficiency, reduce operational costs, and minimize human intervention, making them critical for modern port infrastructure. The increasing integration of digital systems such as Equipment Control Systems (ECS), fleet management platforms, and AI-based analytics is further strengthening automation capabilities across global ports.

Asia Pacific travel and tourism market was valued at $985.0 billion in 2025 and is projected to reach $    1,848.7 billion by 2035, growing at a CAGR of 6.6% during 2026–2035. The market is witnessing steady expansion driven by rising disposable income, increasing regional mobility, and strong government support for tourism development across key economies. A major macro driver fueling growth is the strong recovery in domestic and international travel demand across the Asia Pacific. According to the Ministry of Tourism, Government of India, domestic tourist visits surpassed 1.7 billion in 2023, while foreign tourist arrivals exceeded 9.2 million, highlighting a significant rebound in travel activity. Similarly, data from the Japan National Tourism Organization (JNTO) indicates that Japan recorded over 25 million international visitors in 2023, supported by relaxed visa policies and targeted promotional campaigns.

Artificial Lift Systems market was valued at $9.7 billion in 2025 and is projected to reach $16.7 billion by 2035, growing at a CAGR of 5.7% from 2026 to 2035. The market growth is strongly supported by increasing global oil production demand and the rising need to enhance recovery rates from mature oilfields. Artificial lift systems play a critical role in maintaining production levels by improving reservoir pressure and enabling efficient hydrocarbon extraction. A key macro driver accelerating market expansion is the sustained global demand for crude oil and energy security. In April 2024, SLB launched two advanced artificial lift systems—Reda Agile ESP and Reda PowerEdge ESPCP—designed to boost production efficiency while significantly reducing emissions. These technologies integrate real-time digital monitoring to enhance operational stability, lower costs, and cut CO? emissions by up to 55%. The Agile ESP system has already demonstrated success with Pertamina, delivering sustained performance in a challenging offshore well. These innovations improve production economics, extend well life, and enable more energy-efficient operations, aligning with the growing need for efficient extraction from aging reservoirs.

Antimalarial drugs market was valued at $1.5 billion in 2025 and is projected to reach $2.6 billion by 2035, expanding at a CAGR of 5.3% during the forecast period (2026–2035). The market growth is primarily driven by the persistent global burden of malaria and increasing efforts toward disease elimination across endemic regions. According to the World Health Organization (WHO), global malaria funding reached approximately $4.0 billion in 2023, reflecting continued international commitment toward malaria control and elimination. However, this remains significantly below the estimated $7.8 billion required annually by 2025 to stay on track with global eradication targets. This widening funding gap is driving governments and international organizations to increase investments in cost-effective and scalable antimalarial drug procurement, thereby boosting market demand.

Antibiotics market was valued at $52.9 billion in 2025 and is anticipated to reach $75.2 billion by 2035, expanding at a CAGR of 3.7% from 2026 to 2035. Market growth is primarily driven by the sustained prevalence of infectious diseases and the rising threat of antimicrobial resistance (AMR), which continues to challenge global healthcare systems. According to the World Health Organization, lower respiratory infections remain among the leading causes of mortality worldwide, thereby maintaining consistent demand for antibiotic treatments across both hospital and outpatient settings. Furthermore, estimates from the Organisation for Economic Co-operation and Development suggest that antimicrobial resistance could result in approximately 2.4 million deaths across Europe, North America, and Australia by 2050, emphasizing the urgent need for effective and innovative antibiotic therapies. In addition, the growing number of hospital admissions and surgical procedures is contributing to increased antibiotic consumption, particularly in intensive care and post-operative care settings. Among drug classes, beta-lactams continue to dominate the market due to their broad-spectrum efficacy, safety profile, and cost-effectiveness, while respiratory tract infections represent the largest application segment globally.

Alcoholic Beverages Market size was valued at $4.0 billion in 2025 and is projected to reach $17.5 billion by 2035, growing at a CAGR of 16% between 2026 and 2035. The market growth is primarily driven by increasing global alcohol consumption, premiumization trends, and expanding distribution channels across both developed and emerging economies. A key macro driver supporting market expansion is the rising global alcohol consumption and urban lifestyle shifts. According to the World Health Organization (WHO), global per capita alcohol consumption is estimated at around 5.5 litres of pure alcohol per year, highlighting a large and stable consumer base.

Advanced Therapy Medicinal Products (ATMP) market was valued at $28.5 billion in 2025 and is projected to reach $147.4 billion by 2035, growing at a CAGR of 17.9% during 2026–2035. Advanced Therapy Medicinal Products include gene therapy, cell therapy, tissue-engineered products, and combined ATMPs that integrate biological components with medical devices. These therapies are primarily used in the treatment of oncology, rare genetic disorders, cardiovascular diseases, neurological conditions, and immunological disorders. ATMPs are developed through advanced biotechnological processes involving genetic modification, cellular engineering, and regenerative medicine approaches. ATMPs play an indispensable role in modern healthcare by offering targeted, personalized, and potentially curative treatments.